Literature DB >> 25422258

Selection of living donor liver grafts for patients weighing 6kg or less.

Naoya Yamada1, Yukihiro Sanada, Yuta Hirata, Noriki Okada, Taiichi Wakiya, Yoshiyuki Ihara, Atsushi Miki, Yuji Kaneda, Hideki Sasanuma, Taizen Urahashi, Yasunaru Sakuma, Yoshikazu Yasuda, Koichi Mizuta.   

Abstract

In the field of pediatric living donor liver transplantation (LDLT), physicians sometimes must reduce the volume of left lateral segment (LLS) grafts to prevent large-for-size syndrome. There are 2 established methods for decreasing the size of an LLS graft: the use of a segment 2 (S2) monosegment graft and the use of a reduced LLS graft. However, no procedure for selecting the proper graft type has been established. In this study, we conducted a retrospective investigation of LDLT and examined the strategy of graft selection for patients weighing ≤6 kg. LDLT was conducted 225 times between May 2001 and December 2012, and 15 of the procedures were performed in patients weighing ≤6 kg. We selected S2 monosegment grafts and reduced LLS grafts if the preoperative computed tomography (CT)-volumetry value of the LLS graft was >5% and 4% to 5% of the graft/recipient weight ratio, respectively. We used LLS grafts in 7 recipients, S2 monosegment grafts in 4 recipients, reduced S2 monosegment grafts in 3 recipients, and a reduced LLS graft in 1 recipient. The reduction rate of S2 monosegment grafts for use as LLS grafts was 48.3%. The overall recipient and graft survival rates were both 93.3%, and 1 patient died of a brain hemorrhage. Major surgical complications included hepatic artery thrombosis in 2 recipients, bilioenteric anastomotic strictures in 2 recipients, and portal vein thrombosis in 1 recipient. In conclusion, our graft selection strategy based on preoperative CT-volumetry is highly useful in patients weighing ≤6 kg. S2 monosegment grafts are effective and safe in very small infants particularly neonates.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25422258     DOI: 10.1002/lt.24048

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

1.  Pediatric split liver transplantation using a hyperreduced left lateral segment graft in an infant weighing 4 kg.

Authors:  Jung-Man Namgoong; Shin Hwang; Dae-Yeon Kim; Gi-Won Song; Chul-Soo Ahn; Kyung Mo Kim; Seak Hee Oh
Journal:  Korean J Transplant       Date:  2020-09-30

2.  Pediatric liver transplantation with hyperreduced left lateral segment graft.

Authors:  Jung-Man Namgoong; Shin Hwang; Gi-Won Song; Dae-Yeon Kim; Tae-Yong Ha; Dong-Hwan Jung; Gil-Chun Park; Chul-Soo Ahn; Kyung Mo Kim; Seak Hee Oh; Hyunhee Kwon; Yong Jae Kwon
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-11-30

3.  Dorsal approach plus branch patch technique is the preferred method for liver transplanting small babies with monosegmental grafts.

Authors:  Yukihiro Sanada; Shuji Hishikawa; Noriki Okada; Naoya Yamada; Takumi Katano; Yuta Hirata; Yoshiyuki Ihara; Taizen Urahashi; Koichi Mizuta
Journal:  Langenbecks Arch Surg       Date:  2016-07-26       Impact factor: 3.445

4.  Rescue case of low birth weight infant with acute hepatic failure.

Authors:  Noriki Okada; Yukihiro Sanada; Taizen Urahashi; Yoshiyuki Ihara; Naoya Yamada; Yuta Hirata; Takumi Katano; Kentaro Ushijima; Shinya Otomo; Shujiro Fujita; Koichi Mizuta
Journal:  World J Gastroenterol       Date:  2017-10-28       Impact factor: 5.742

5.  Computed tomography donor liver volumetry before liver transplantation in infants ≤10 kg: does the estimated graft diameter affect the outcome?

Authors:  Nagoud Schukfeh; Maren Schulze; Anna Charlotte Holland; Jens Dingemann; Dieter P Hoyer; Andreas Paul; Jens M Theysohn
Journal:  Innov Surg Sci       Date:  2018-07-03

Review 6.  Alternatives to left lateral sector in paediatric liver transplantation-a systematic review on monosegmental and reduced grafts.

Authors:  Paschalis Gavriilidis; Ernest Hidalgo
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.